`
`
`
`
`IPR2016-00357, Paper No. 56
`IPR2016-00358, Paper No. 55
`IPR2016-00359, Paper No. 57
`March 30, 2017
`
`trials@uspto.gov
`
`
`571-272-7822
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`GENERAL ELECTRIC CO.,
`Petitioner,
`
`v.
`
`UNIVERSITY OF VIRGINIA PATENT FOUNDATION,
`Patent Owner.
`____________
`
`Case IPR2016-00357
`Case IPR2016-00358
`Case IPR2016-00359
`Patent RE44,644
`____________
`
`Held: March 2, 2017
`____________
`
`
`
`BEFORE: KARL D. EASTHOM, J. JOHN LEE, and
`TREVOR M. JEFFERSON, Administrative Patent Judges.
`
`
`
`
`
`The above-entitled matter came on for hearing on Thursday,
`March 2, 2017, commencing at 9:34 a.m., at the U.S. Patent
`and Trademark Office, 600 Dulany Street, Alexandria,
`Virginia.
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`APPEARANCES:
`
`ON BEHALF OF THE PETITIONER:
`
`
`
`
`
`
`
`
`
`
`
`ON BEHALF OF PATENT OWNER:
`
`
`
`
`
`
`
`
`DAVID POLLOCK, ESQUIRE
`BRIAN D. ROCHE, ESQUIRE
`JONATHAN I. DETRIXHE, ESQUIRE
`Reed Smith, LLP
`101 Second Street, Suite 1800
`San Francisco, California 94105
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`JOSEPH F. DePUMPO, ESQUIRE
`ARI B. RAFILSON, ESQUIRE
`Shore, Chan, DePumpo, LLP
`901 Main Street, Suite 3300
`Dallas, Texas 75202
`
`and
`
`RODNEY L. SPARKS, J.D., Ph.D.
`University of Virginia Innovation
`
`
`
`
`
` 2
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`P R O C E E D I N G S
`- - - - -
`JUDGE LEE: Good morning everyone. Welcome to
`the Board. This is the oral hearing in case number
`IPR2016-00357, 2016-00358, and 2016-00359 concerning U.S.
`Patent Number RE44,644. We'll start this morning with
`appearances by counsel. Counsel for petitioner, if you could step
`to the podium and make your appearance.
`MR. POLLOCK: Good morning, Your Honor. I'm
`David Pollock with Reed Smith for petitioner, General Electric.
`With me are my colleagues, Brian Roche and John Detrixhe.
`JUDGE LEE: Good morning. Counsel for patent
`
`owner?
`
`MR. SPARKS: Good morning, Your Honors. I'm
`Rodney Sparks, counsel for the University of Virginia Patent
`Foundation. My colleagues, my backup counsel, who will be
`speaking are Joe DePumpo and Ari Rafilson.
`JUDGE LEE: Good morning. Each side will have
`60 minutes to make their presentations. Petitioner, you have the
`option of reserving time for rebuttal. Would you like to do that?
`MR. POLLOCK: Yes, Your Honor, we would like to
`reserve 15 minutes for rebuttal, please.
`JUDGE LEE: Fifteen minutes for rebuttal. That gives
`you 45 minutes for your main presentation. Are you ready to
`begin?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 3
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`MR. POLLOCK: Yes, we are, Your Honor.
`JUDGE LEE: Before you start, let me first say that we
`have reviewed both sides' objections to demonstrative exhibits.
`We have elected to reserve judgment on them. We do advise
`both parties that to the extent that demonstratives you present
`include new arguments not previously presented, those arguments
`will be disregarded. And with that, you may proceed.
`MR. POLLOCK: Thank you, Your Honor. Good
`morning, Judges Lee, Easthom and Jefferson. I, David Pollock,
`will be presenting the 102(b) and 103 portions of General
`Electric's argument and my colleague, Mr. Roche, will be
`presenting the 102(a) portion of the argument.
`Now, in its institution decisions for purposes of
`instituting trial, the Board determined that Mugler 2000 is prior
`art under both 102(b) and 102(a) and instituted reviews on
`multiple grounds for all of the challenged claims. And here is a
`summary of the various invalidity grounds for each challenged
`claim prepared for the Board's convenience. Most of these
`grounds include Mugler 2000, but the last two include reliance on
`Mugler '99.
`Now, although patent owner disputes whether Mugler
`2000 is available as prior art, patent owner does not dispute that if
`available, all the challenged claims are invalid. Patent owner
`disputed invalidity over certain 103 combinations, including
`Mugler '99, in its responses but does not do so in its
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 4
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`demonstratives. So it's unclear whether any dispute over the 103
`obviousness grounds are in dispute.
`This IPR is unusual. It turns primarily on written
`description and authorship issues. Not on the typical prior art
`disclosure issues. Regarding the 102(b) issue, the dispute is
`whether the provisional '182 application provides adequate
`written description support for each of the challenged claims. In
`its institution decisions the Board found for many reasons that it
`did not. GE believes the Board got it right and patent owner
`believes the Board got it wrong. Although there are a few factual
`disputes here, the disputes before the Board are primarily disputes
`of law. What is adequate written description support and what
`can be considered as part of the written description, those are
`both legal issues.
`Now, a disclosure must disclose the invention with all
`of its claim limitations. No limitation can be entirely missing. A
`disclosure that renders the invention merely obvious is not
`sufficient. This is an important point. Although the collection of
`limitations need not be present in haec verba, as it says in the
`Lockwood case, each limitation must be present. Not merely
`obvious or just well known.
`Now, what does the invention with all its limitations
`actually mean? The Novozymes case tells us each claim must be
`disclosed as an integrated whole rather than a collection of
`independent limitations. These limitations cannot be spread
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 5
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`around the disclosure. They must be regarding one species of the
`invention. As GE pointed out in its replies, patent owner
`analyzed individual limitations but failed to make any arguments
`that each claim is disclosed in its entirety. Patent owner has thus
`failed to argue a key part of the written description test, and this
`shortcoming alone is fatal to their case.
`Now, for disclosing claimed ratios, there's specific
`guidance in the Purdue Pharma case. It is not enough that the
`feature could be pieced together based on examples in the
`specification. It's there on the left. There must be text or data or
`something that emphasizes the ratio. The Purdue Court called
`these blaze marks, and so the written description for a ratio or
`range of ratios, the blaze marks directing the skilled artisan to that
`trait must be in the original disclosure. As I'll explain, the '182
`application fails to include the required text, data or anything else
`emphasizing the ratios.
`Now, the written description test is often expressed as
`whether a person of ordinary skill would understand that the
`patentee had possession of the claimed invention at the time of
`the claimed invention. The Federal Circuit, in its en banc Arida
`case, observed that the term "possession" has never been very
`enlightening and stated that the test is better presented as
`possession as shown in the disclosure which requires an inquiry
`into the four corners of the specification.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
` 6
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`Now, throughout this proceeding patent owner has
`shown that it misunderstands the written description requirement.
`In its preliminary responses patent owner argued that if the claims
`are anticipated by Mugler 2000, they must be adequately
`supported by the more detailed '182 application. This was legal
`error. And the Board explained that in its institution decisions
`that a disclosure can anticipate a broad claim by disclosing one
`embodiment within the scope, but that same disclosure would not
`provide 112 support unless the disclosure shows possession of the
`full scope of the broad claim. This is an important distinction
`between 102 and 112. 102 requires one example; 112 requires
`possession of the full scope of the claim. As the Board observed,
`102 and 112 are fundamentally different tests. Patent owner
`confuses those tests.
`In its responses, patent owner still fundamentally
`misunderstands the written description case law. Patent owner
`now asserts that the written disclosure requirement turns upon the
`knowledge of a person of ordinary skill in the art. That's not true.
`It turns upon the disclosure in the priority document. Not the
`knowledge of one of skill in the art. And in support, PO cites
`only to an unreported order on a motion in limine regarding
`admissibility of prior art. This is not a 112 case. This is a motion
`in limine. And that order in the motion in limine states
`Section 112 takes into account the prior art through the
`knowledge of one skilled in the art at the time the invention was
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 7
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`made. Patent owner's reliance on this case is misplaced. This is a
`motion in limine and not a 112 case.
`JUDGE LEE: Mr. Pollock, you don't dispute that
`although a disclosure must actually appear in the written
`description, that that disclosure is read and interpreted from the
`perspective of a person of ordinary skill in the art, including their
`knowledge in the art? You don't dispute that, right?
`MR. POLLOCK: Judge Lee, I'm glad you asked that
`question. Here in slide 14 the Lockwood case tells us the
`knowledge of one of skill in the art does have a role, but that role
`is very limited. It's only for interpreting the meaning of the
`disclosure. So you can look at a word in the disclosure and
`decide what it means, a small word, say, for example, an MR
`scanner, that discloses a great deal of information, from the
`power cord through the magnets, everything else. So if it just
`says an MR scanner, that word can be interpreted to mean very
`many things. But if that word is not there, if there's no mention,
`then that word -- then there is no disclosure.
`So interpreting from the vantage point of one of skill in
`the art is not the same as bringing the knowledge of one of skill in
`the art into a disclosure and inserting it there. Now, Dr. Hennig
`admitted exactly this. He admits that his written description
`analysis added all the knowledge of one of skill in the art to the
`specification. Dr. Hennig admitted that during deposition. And
`that is fundamentally incorrect.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 8
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`Even on redirect, after an hour of preparation,
`Dr. Hennig testified that a person of ordinary skill in the art is
`able to fill in the gap between a specification and the claim
`language. The only restriction he applied is the gap cannot be
`arbitrarily large. The knowledge of one of skill in the art cannot
`be used to put into a disclosure information that is not there.
`Only to interpret, Judge Lee, as you observed.
`Now, another fundamental error in patent owner's and
`its expert analysis is consideration of material not properly within
`the specification. Now, of course outside material can be
`incorporated into a patent by reference, but there are two strict
`requirements for that incorporation, both of which patent owner's
`art fails. First the material must be identified with detailed
`particularity. And second, the incorporation must be for a
`particular stated purpose. Unless the incorporation statement
`includes this detailed particularity and a particular stated purpose,
`the incorporation fails as a matter of law. This issue is a matter of
`law for the Court to decide.
`Now, patent owners --
`JUDGE LEE: Mr. Pollock, I know that this wasn't in
`the briefing, but are you familiar with the case Harari v. Lee, 656
`F.3d 1331?
`MR. POLLOCK: I'm not familiar with it, Your Honor.
`JUDGE LEE: As I understand that case, the Federal
`Circuit, in that case, held that two patent applications were
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 9
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`incorporated by reference in their entirety using language pretty
`similar to what is in the provisional application in this case. So
`what about that? And there are other cases as well, Advanced
`Display Systems v. Kent State University. There does seem to be
`some ambiguity about exactly how you incorporate references in
`a disclosure, whether doing it in its entirety is okay or not.
`MR. POLLOCK: And if the reference is short enough,
`Your Honor, and then perhaps incorporating something in its
`entirety would be permitted. But there are also two prongs to this
`test, and there are some cases that have been sloppy and courts
`have not considered both prongs of the test. I have legion case
`law that shows that there is a test and it has two prongs. So
`certainly there may be an example of cases that did consider a
`reference incorporated in its entirety because it's short, and there
`are also cases that didn't perform the required analysis because
`the litigants didn't put the issue before the Court. But the cases of
`which GE is aware, there is a two-prong test, and you must pass
`both prongs in order to be considered incorporated by reference.
`Now, these requirements are of course part of the public
`notice function of a patent. And they prevent exactly the sort of
`mischief that patent owner is seeking to make here. Post-talk
`reliance on unspecified snippets of thousands of pages
`incorporated by reference in general for no stated purpose is
`unfair. It's unfair to the public because it doesn't put the public on
`notice of what the invention is. That's the purpose of the
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 10
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`specification. And here patent owner cites, I believe, 21 separate
`references for no purpose and no particular part, and it shouldn't
`be permitted. It should not be the law that a patent owner can
`provide a dearth of disclosure, incorporate a great number of
`references for no purpose and then later on rely upon them for
`112 disclosure -- sorry, to meet the 112 written description test.
`Does that answer your question, Judge?
`JUDGE LEE: For the time being. Please proceed.
`MR. POLLOCK: Now, in its institution decisions, the
`Board determined that Mugler 2000 is prior art under 102(b)
`because four particular limitations were missing. Now, on
`described limitation number 1, the magnetic field gradient pulses,
`that applies to all the challenged claims. And then collectively
`what I'll refer to as the range limitations, missing limitations 2, 3
`and 4, those collectively also apply to all the challenged claims.
`So if the Board finds for GE on either 1 or 2, 3 and 4, all of the
`claims are invalid. There is no dispute.
`Now, the Board agreed in its institution decision --
`JUDGE LEE: You don't mean that the claims are --
`they are not invalid for written description purposes, right?
`MR. POLLOCK: Correct, Your Honor. That issue is a
`subsidiary issue here. Those claims are invalid over Mugler 2000
`because the '182 application doesn't provide the priority necessary
`to antedate Mugler 2000. Sorry. I should have been more clear.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
` 11
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`Now, in its institution decisions, the Board determined
`that at least one includes only one. And of course it does. The
`Board agreed that there was no written description of encoding
`spatial information into only one of the signals for only one of the
`refocusing pulses. And on that ground it found that the '182
`application did not find priority.
`Now, patent owner does not dispute this lack of
`disclosure under the plain meaning of the claim. In its response,
`patent owner tries to save its patent by inserting the word
`"individually" into this claim limitation and then arguing that the
`only-one-only-one scope is disclosed under its narrower
`construction inserting the word "individually" into the claim.
`There is no argument and there is no dispute that without
`individually, the only-one-only-one portion of the disclosure is
`not there. It's missing. The Board found it in its institution
`decisions and there's no argument to the contrary.
`JUDGE LEE: I'm not sure I understood patent owner's
`argument necessarily to say that. In fact, I'm not exactly sure
`what the word "individually" adds or subtracts from the claim.
`But I did understand patent owner and its expert, Dr. Hennig, to
`argue that the mention in the provisional application of RARE
`imaging does indicate a one signal encoding situation. Is that not
`true?
`
`MR. POLLOCK: That's not true, Your Honor. If you
`look in their response, the argument about RARE is a subportion
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 12
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`under the argument about individually. And this ambiguity in the
`petitioner's briefing creates this confusion. There still is no
`dispute that without the word "individually" that RARE does not
`disclose the only-one-only-one.
`JUDGE LEE: Isn't it true, though, that RARE imaging
`does encode spatial information into only one signal following
`each refocusing pulse?
`MR. POLLOCK: Well, it depends on your insertion of
`the word "each" there. So what patent owner would have the
`Board do is rewrite the claim to say providing magnetic field
`gradient pulses that individually perform encoding spatial
`information into at least one of the radio frequency magnetic
`resonance signals to follow at least one of the radio frequency
`pulses. That is a narrowing of the claim. That is examining the
`claim for each magnetic field gradient pulse rather than magnetic
`field gradient pulses collectively, as the claim states. That is a
`very important issue here, Your Honor. The patent owner is
`trying to narrow the claim in order to create a disclosure of the
`only-one-only-one embodiment.
`JUDGE LEE: I'm not sure that it is clear that referring
`to magnetic field gradient pulses, plural, that perform particular
`functions requires a reading that all of them collectively perform
`that function. As I understand what you are saying, the claim
`must be read to say that all of the magnetic field gradient pulses
`encode into only one signal. Do I understand you properly?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 13
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`MR. POLLOCK: Yes, Your Honor. That's what the
`unrefuted expert testimony says. There is no analysis by
`Dr. Hennig that if you put -- without the word "individually" that
`all of the magnetic field gradient pulses encoded to
`only-one-only-one.
`There's also a backlash to the insertion of
`"individually." And patent owner is trying to have it both ways.
`Patent owner argues for purposes of the only-one-only-one
`portion that "individually" is there. And then patent owner argues
`out the other side of its mouth that with individually, that the
`more-than-one-more-than-one portion is there. And patent owner
`can't have it both ways. Either the claim requires examination of
`the gradient -- magnetic field gradient pulses individually in
`which case more-than-one-more-than-one portion of the
`disclosure is simply not there or collectively in which case the
`only-one-only-one portion of the claim is not there. And these
`inconsistent positions have created this confusion.
`We invite the Board to examine this closely. There's no
`dispute that if "individually" is added, the
`more-than-one-more-than-one portion is not disclosed. There's
`no expert evidence to the contrary, and the only expert evidence
`is that it's not disclosed.
`JUDGE LEE: In the scenario that you are referring to
`where all of the pulses, every single one together must encode
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
` 14
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`into only one signal, that would not be considered spin echo train
`imaging, that’s something that Dr. Pelc agreed to, right?
`MR. POLLOCK: You are right, Your Honor. That's a
`function of a miswritten claim. It's a poorly drafted claim, and
`the patent owner needs to live with that, at least live with the
`ramifications of the claim as written.
`JUDGE LEE: If, just assuming for the moment, that we
`read the claim to not require that all of the pulses together must
`encode into only one and that it can be read so that a pulse, a
`gradient pulse encodes into one or more than one, what is wrong
`with that? You referred to a more-than-one-more-than-one
`scenario. Can you be more clear about what you are referring to?
`MR. POLLOCK: Sure, Your Honor. I appreciate the
`question. We have slides addressing that.
`So here on slide 20 patent owner's argument assumes
`there's a one-to-one correspondence between a line of k-space and
`an MR signal. And both Dr. Hennig and Dr. Pelc agree that this
`assumption is not correct.
`Actually, I'll go back to slide 19. I apologize. So
`although GE maintains that adding "individually" is improper,
`even if individually is added, PO fails to attempt to show that the
`full scope of the claim is disclosed. In particular, PO fails to
`argue that if "individually" is added, the more than one following
`more than one part of the claim scope is disclosed. As I said,
`there is no argument in its response, no Hennig testimony that
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 15
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`more-than-one-more-than-one is disclosed with "individually"
`added.
`
`And in fact, the only expert testimony is by Dr. Hennig.
`And it says in paragraph 9 if "individually" is added, the claim
`would now include within its scope gradient pulses that
`individually encode resonance signals that follow more than one
`radio frequency pulse. And there's no teaching of that. There's
`no contrary Hennig testimony. There's no even argument,
`unsupported attorney argument that that's the case. That's
`uncontroverted.
`And here patent owner does dispute part of this. Patent
`owner disputes more-than-one-only-one but patent owner's
`argument about more-than-one-only-one also fails. Patent
`owner's argument that there's a one-to-one correspondence
`between a line of k-space and an MR signal is simply incorrect.
`It relies on -- and both Dr. Hennig and Pelc agree about this. You
`can see Dr. Hennig's testimony on the left. Dr. Hennig says that a
`line of k-space and an MR signal is apples and pears. Likewise,
`Dr. Pelc says there is not a one-to-one correspondence between a
`line of k-space and an MR signal. So contrary to patent owner's
`argument regarding GRASE, disclosure of GRASE does not
`provide support for a gradient pulse that individually encodes
`spatial information into more than one RF MR signal following
`only one refocusing pulse. And there's simply no dispute about
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`
` 16
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`the more-than-one-more-than-one part of the language under this
`individually claimed construction.
`JUDGE LEE: Are you aware of any MRI techniques in
`the art where there are multiple refocusing pulses before any
`signal is sent?
`MR. POLLOCK: I am not, Your Honor. I'm aware
`only of what's in the disclosure of the '182 application. I'm not a
`Ph.D. in the MR science, but in the '182 application, as
`Dr. Hennig says, there is no explicit teaching in the '182
`application or the '644 patent of individually encoding magnetic
`resonance signals that follow more than one radio frequency
`pulse. It's simply not there. More important, patent owner has
`not pointed to anything and there's no expert testimony that
`contradicts it. As we said, Your Honor, the patent owner can't
`have it both ways. If you insert individually to address one
`problem, it creates this other problem of
`more-than-one-more-than-one-more-than-one.
`Any further questions on that, Your Honor, before I
`proceed?
`JUDGE EASTHOM: Can you go back to the previous
`slide, please, 21, I think. This one, what about the sentence on
`the right, the second sentence, however, in GRASE imaging
`measurement of one MR signal following one
`radiofrequency refocusing pulse acquires data for three or more
`lines of k-space, isn't that the individually more than one?
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 17
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`
`MR. POLLOCK: Your Honor, that would be more than
`one if a line of k-space corresponded to an MR signal. But it
`simply does not. As Dr. Hennig admitted during deposition,
`those are apples and pears. Patent owner makes this argument.
`They say, well, there's more than one line of k-space encoded, but
`that's different than an MR signal.
`JUDGE LEE: I don't see that testimony as saying that a
`line of k-space and one signal is apples and pears. It seems to me
`he's saying, and I'm quoting here, a signal is something that you
`measure on your oscilloscope and the spatial encoding is what
`you use to make an image so that there are two different things --
`those are two different things. Not necessarily that the one-to-one
`relationship is not valid. In fact, isn't it something he testified to
`in the immediate preceding page where he said that it is typically
`a one-to-one relationship?
`MR. POLLOCK: Often it is. Often a signal encodes
`into one line of k-space, but they are not the same thing. And
`patent owner's argument is about a signal -- sorry, is not about a
`signal. It's about a line of k-space. So there's this bait and switch
`on the Board, Your Honor, where the only argument for the
`more-than-one-only-one is that a line of k-space is the same as a
`signal.
`
`The claim language, the claim language says only one
`MR signal. It doesn't say only one line of k-space. And GRASE
`certainly encodes three lines of k-space, but it's only one signal.
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 18
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`And I can show that to you right here. The signal has one spin
`echo in the center and then a gradient echo signal on either side.
`More important, the claims exclude that gradient echo signal.
`The claims say the radiofrequency magnetic resonance signal is a
`signal evolution for the associated train of spin echos. Not the
`associated train of spin echos with a gradient echo signal on
`either side.
`So the claim makes crystal clear that the spin echo pulse
`sequence is regarding the spin echos. Not the spin echos plus
`gradient echos that occur in GRASE. So if you look at just the
`spin echos, there's only one spin echo in the center. There are not
`multiple spin echos. There's only one.
`JUDGE EASTHOM: Which one is the spin echo on
`
`there?
`
`MR. POLLOCK: The spin echo is the echo in the
`center of Figure 3, the top line. So gradient-recalled echo signal
`on the left in the red box.
`JUDGE JEFFERSON: For clarity of the transcript, you
`might want to indicate what slide you are looking at.
`MR. POLLOCK: On slide 22, in Figure 3, there are
`three amplitude gradient-recalled echo signals, one spin echo in
`the center of each. The echos on either side, those are
`gradient-recalled echos and they are not included within the scope
`of the claim. So because the claim points to only a train of spin
`echos and not gradient echos, there is only one signal. And that
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 19
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`falls outside of the scope of the claim, and therefore, the entire
`scope of the claim is not disclosed by the '182 application. This
`is very important.
`I would like to go on to the effective echo time, Your
`Honors, if I may. So the effective echo time, this is the second
`limitation the Board found undescribed, and it says an effective
`echo time is at least twice an effective echo time for a turbo spin
`echo or fast spin echo train pulse sequence or an echo time for
`said conventional spin echo pulse sequence.
`So one includes a comparison of the effective echo time
`to a turbo spin echo sequence, and the other is a comparison of
`the echo time to a conventional spin echo sequence. Now, this
`limitation has two parts. It's ratio of the new effective echo time
`to either the turbo spin echo or spin echo time and the ratio must
`be at least twice. Neither part of this ratio is disclosed.
`The '182 application discloses only one example of an
`effective echo time and that's 328 milliseconds. PO does not and
`cannot dispute this fact. And the '182 application does not
`compare the effective echo time to any other value. Again, PO
`does not dispute and cannot dispute this fact. There's also no
`disclosure or expression of the effective echo time value as a ratio
`compared to any value or any range of values. And that's beyond
`dispute.
`Now, on slide 28, the '182 application does provide a
`single example of an echo time for a conventional spin echo
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`15
`16
`17
`18
`19
`20
`21
`22
`23
`24
`25
`
` 20
`
`
`
`
`
`
`
`Case IPR2016-00357, Case IPR2016-00358
`Case IPR2016-00359, Patent RE44,644
`
`sequence of 80 milliseconds. But it does not compare this echo
`time to the effective echo time of the disclosed sequence. Again,
`this is beyond dispute. Now, if such a comparison is made, and
`there is no reason to do so, the ratio is 4.1. It's not twice.
`Now, PO's expert, Dr. Hennig, admitted that there's not
`a comparison of 328-millisecond effective echo time value to the
`80-millisecond conventional time value. He says that they are
`specified but there's no comparison there. Again, this is beyond
`dispute.
`Now, this lack of disclosure is dispositive under Purdue
`Pharma. In fact, by now claiming these undisclosed ratios, PO is
`doing exactly what's forbidden by the Federal Circuit in Purdue
`Pharma. Picking a characteristic not discussed even in passing in
`the disclosure and then making it the basis of the claims, that's
`exactly the type of overreaching the written description
`requirement was designed to guard against. The result in Purdue
`Pharma of invalidity is the same as the result should be here.
`Now, patent owner also does not dispute that there's no
`disclosure of the lower bound, the lower bound of twice. Instead,
`patent owner argues merely that the skilled artisan could
`indirectly reduce the echo time ratio by reducing the echo train
`length and could even reduce it down to twice if desired. Well, of
`course a skilled artisan could do a lot of things, but there is no
`teaching in the patent for the skilled artisan to do this. There's no
`teaching of a ratio. There is no teachi